BioCentury
ARTICLE | Company News

Panacea Pharmaceuticals, JSR Corp. deal

December 15, 2003 8:00 AM UTC

JSR will use its magnetic particle fabrication technology and surface chemistry to develop assays that measure human aspartyl (asparaginyl) beta-hydroxylase ( HAAH) for use in Panacea's HAAH oncology...